1. Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) or a salt or ester thereof, for use in the treatment of a condition selected from the group consisting of macular edema, a condition causing damage to retinal photoreceptors and / or retinal pigment epithelial cells and dry eye in a mammal, wherein the dosage of the combination of eicosapentaenoic acid and docosahexaenoic acid is from 5 mmol to 25 mmol per day, and the molar ratio of eicosapentaenoic acid to docosahexaenoic acid ranges from 1: 5 to 1: 1.2. Eicosapentaenoic acid and docosahexaenoic acid according to Claim. 1, the condition is macular edema or dryness glaz.3. Eicosapentaenoic acid and docosahexaenoic acid according to Claim. 1, the state is yellow pyatna.4 edema. Eicosapentaenoic acid and docosahexaenoic acid according to para. 3, wherein the macular edema is caused by or associated with wet age-related macular degeneration, diabetic retinopathy, retinal vascular occlusion and / or inflammation glaz.5. Eicosapentaenoic acid and docosahexaenoic acid according to para. 3 for use in the treatment group patients, little susceptible to treatment or refractory inhibitor VEGF.6. Eicosapentaenoic acid and docosahexaenoic acid according to para. 4 for use in the treatment group of patients, there is little or susceptible to refractory VEGF.7 inhibitor treatment. Eicosapentaenoic acid and docosahexaenoic acid according to Claim. 1, the state is glaz.8 dryness. Eicosapentaenoic acid and docosahexaenoic acid according to para. 7, wherein a dry eye condition in a moderate or severe pho1. Эйкозапентаеновая кислота (ЭПК) и докозагексаеновая кислота (ДГК) или их соль или сложный эфир, для применения с целью лечения состояния, выбранного из группы, включающей отек желтого пятна, состояния, вызывающие повреждение фоторецепторов сетчатки и/или клеток пигментного эпителия сетчатки и сухость глаз у млекопитающих, при этом комбинированная дозировка эйкозапентаеновой кислоты и докозагексаеновой кислоты составляет
